Anticardiolipin Antibody in Graves' Disease.
- Author:
Young Ki SONG
;
Ki Soo KIM
;
Jung Hee LEE
- Publication Type:Original Article
- Keywords:
Anticardiolipin antibody;
Graves disease
- MeSH:
Abortion, Habitual;
Antibodies, Anticardiolipin*;
Antibodies, Antiphospholipid;
Antiphospholipid Syndrome;
Autoimmune Diseases;
Autoimmunity;
Drug Therapy;
Female;
Graves Disease*;
Humans;
Immunoglobulin G;
Immunoglobulin M;
Lupus Coagulation Inhibitor;
Lupus Erythematosus, Systemic;
Pregnancy;
Thromboembolism;
Thyroid Nodule
- From:Journal of Korean Society of Endocrinology
1997;12(4):528-532
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUNDS: Antiphospholipid antibodies which are frquently found in systemic lupus erythematosus and primary antiphospholipid syndrome are associated with recurrent abortions and thromboembolism. In this study the authors investigated whether antiphospholipid antibodies are found in Graves disease, a representative organ-specific autoimmune disease and what is the clinical implication of the antiphospholipid antibodies if they appear in Graves disease. METHODS: Anticardiolipin antibody and lupus anticoagulant activity were measured in 57 untreated hyperthyroid Graves patients. 42 euthyroid patients with thyroid nodules served as controls. RESULTS: Eight of the 57 patients with Graves disease had anticardiolipin antibody which was significantly more frequent than in control group. Six of the eight patients who had anticardiolipin antibody had IgM type antibody and two had IgG type antibody. All their antibody activity declined with several months of antithyroid drug therapy and finally disappeared when the patients became euthyroid. Presence of anticardiolipin antibody had no relationship with clinical events such as spontaneous abrtion and thromboembolism. CONCLUSION: Anticardiolipin antibody is frequently found in patients with Graves disease. They seem to appear as an epiphenomenon of autoimmunity and they seem not to have any clinical implications.
